ID

22314

Beskrivning

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Concomitant Medications Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast

Länk

https://clinicaltrials.gov/ct2/show/NCT00078572

Nyckelord

Versioner (1)
  1. 2017-05-29 2017-05-29 -
Uppladdad den

29 maj 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

Engelsk

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

1 Formulär  
Concomitant Medications
Beskrivning

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Drug, Trade name preferred
Beskrivning

Drug

Datatyp

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
Date started
Beskrivning

Date started

Datatyp

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
Check if started Pre-study
Beskrivning

started Pre-study

Datatyp

text

Alias
UMLS CUI [1]
C2347852
Date stopped
Beskrivning

Date stopped

Datatyp

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
Check if continued Post- study
Beskrivning

continued Post- study

Datatyp

text

Alias
UMLS CUI [1]
C2347852
Conditions treated/ indication
Beskrivning

Conditions treated or indication

Datatyp

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C2347852
Tillbaka till toppen

Similar models

XELODA and Lapatinib Advanced or Metastatic Breast Cancer Concomitant Medications NCT00078572

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Drug
Item
Drug, Trade name preferred
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
Date started
Item
Date started
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Check if started Pre-study
text
C2347852 (UMLS CUI [1])
started Pre-study
Code List
Check if started Pre-study
CL Item
Yes (Y)
CL Item
No (N)
Date stopped
Item
Date stopped
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Check if continued Post- study
text
C2347852 (UMLS CUI [1])
started Pre-study
Code List
Check if continued Post- study
CL Item
Yes (Y)
CL Item
No (N)
Conditions treated or indication
Item
Conditions treated/ indication
text
C3146298 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial